Category:
Life Sciences
Client:
Qu IBD
Qu IBD
QBECO SSI is a new investigational treatment for inflammatory bowel disease.
Rather than suppressing the immune system like current IBD treatments, QBECO SSI is designed to restore the body’s innate immune system and correct the dysfunctional immune response. Participants are being enrolled in a clinical trial to study QBECO SSI for the treatment of ulcerative colitis.
